Evangelia Maria Tsapakis
Since 2011, Dr Evangelia Maria Tsapakis, BSc(Hons), MBBS, MSc, MRCPsych, PhD(London), directs the “Aghios Charalambos” Mental Health Clinic
Dr Evangelia Maria Tsapakis, BSc(Hons), MBBS, MSc, MRCPsych, PhD(London), is a Consultant Psychiatrist (CCT in General Adult Psychiatry, UK, 2011) who studied pharmacology at King’s College London and medicine at St. George’s Hospital Medical School, University of London.
Having earned the first prize in psychological medicine (the Arthur Crisp Prize), she went on to train in psychiatry at the Royal Bethlem and Maudsley Hospitals.
She has worked under Ross Baldessarini’s mentorship at Harvard Medical School whilst on the 2003 Traveling Fellowship awarded by the Royal College of Psychiatrists, UK. In 2007, she earned a Masters in Affective Neuroscience from the University of Maastricht.
In 2009, she earned a PhD in pharmacogenetics (on the role of metabolic enzyme variants in response to treatment with psychotropic agents) and pharmacogenomics (on the differential gene expression induced by antidepressants in juveniles) at the Institute of Psychiatry, London, UK.
Articles & Awards
She has co-authored several original articles and a book titled: “Handbook of Schizophrenia”, published in 2005. Dr Tsapakis’ awards include a Young Scientist Award at the 11th Biennial Winter Workshop on Schizophrenia (2002), a Research Award at the 5th International Neuropsychiatry Congress (2004), a Young Investigator Award for the 20th International Congress in Schizophrenia Research (2005), and a Poster Prize at the 3rd International Congress on Brain and Behaviour (2007).
She is a member of several international professional organizations including ECNP, BAP and WSPG.
Dr Tsapakis is currently a visiting research associate and collaborator at the International Bipolar Program at Harvard Medical School, Boston, MA.
Activity & Interests
Since 2011, she directs the “Aghios Charalambos” Mental Health Clinic in Heraklion, Crete, Greece, whilst pursuing her research interests through several collaborations with the Universities of Crete and Athens in Greece, the University of Oslo in Norway, the University of Alberta in Canada, and Harvard Medical School in the USA. In 2013, she received a Greek Ministry of Education grant (as a PI) to study clinical pharmacogenetics in the treatment of negative and cognitive symptoms in psychosis.